RecruitingNot ApplicableNCT02155621

Personalized Oncogenomics (POG) Program of British Columbia

Personalized OncoGenomics (POG) Program of British Columbia: Connecting Cancer Genomics to Cancer Care

Sponsor

British Columbia Cancer Agency

Enrollment

5,000 participants

Start Date

Jul 1, 2014

Study Type

INTERVENTIONAL

Conditions

Advanced cancers Metastatic Cancers Cancers That Cannot be Treated With Curative Intent

Summary

The genomic heterogeneity of cancers implies that to effectively use targeted therapies the investigators will need to assess each individual cancer and match it to a biologically relevant targeted therapy. The investigators will use full genome sequencing to try to identify cancer "drivers" and corresponding drugs that may inhibit these pathways.

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Genome sequencing for people with advanced cancers, cancers that cannot be treated with curative intent, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.